Ultime notizie per ZHONGCHAO (NASDAQ:ZCMD) Azioni

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

ZHONGCHAO Inc

Wedbush analyst Dan Ives is out with a new note laying the groundwork for Tesla Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) highly anticipated robotaxi event, expected to introduce new <a href="https://www.benzinga.com/news/24/09/41086839/tesla-cybertruck-starts-receiving-highly-anticipated-fsd-software">&#8220;game changing&#8221; technology</a>.
What To Know: Ives released a new note to clients late Monday, reiterating Tesla with an Outperform rating and price target of $300 ahead of the EV company&#8217;s long-awaited &#8220;We, Robot&#8221; event set for Oct. 10.
&#8220;We believe Robotaxi Day will be seminal and historical day for Musk and Tesla and marks a new chapter of growth around autonomous, FSD, and AI future at Tesla,&#8221; Ives said in a note to clients. 
The Wedbush analyst anticipated several &#8220;game changing&#8221; updates and details surrounding Tesla&#8217;s robotaxi platform, rumored to be called the &#8220;Cybercab.&#8221; Ives laid out expectations for updates on scaling the Cybercab, overall costs per mile, a potential ride-share app and a first-gen demonstration.
Given the anticipation surrounding the event, Ives expects CEO Elon Musk to address near-term investor concerns related to the robotaxi and explain the company&#8217;s longer-term vision for the technology. 
Check This Out: <a href="https://www.benzinga.com/general/entertainment/24/09/41101369/tesla-ev-fire-in-garage-goes-viral-during-hurricane-helene-while-cybertruck-owners-engage-w">Tesla EV Fire In Garage Goes Viral During Hurricane Helene, While Cybertruck Owners Engage Wade Mode</a>
Tesla is also likely to focus on recent breakthroughs with its full self-driving (FSD) software and <a href="http://benzinga.com/topic/ai">AI</a> initiatives. Tesla&#8217;s FSD has now logged over 1.5 billion miles in Tesla&#8217;s datacenters and the company&#8217;s latest FSD release has been deemed a significant upgrade over its predecessor, Ives said.
FSD 13 is expected to be released before the end of the year. The Wedbush analyst will be watching for any updates on the next release, which is expected to introduce new features like autonomous parking and reversing capabilities and offer a 6x improvement in miles-per-intervention. 
Ives also noted Tesla&#8217;s <a href="http://benzinga.com/topic/optimus">Optimus</a> bot continues to pique interest. Tesla is currently targeting sales of its humanoid robots by 2026. The analyst anticipates updates on Optimus development at next week&#8217;s robotaxi event.
&#8220;We believe this is a pivotal time for Tesla as the company prepares to release its years of Robotaxi R&amp;D shadowed behind the curtains, while Musk &amp; Co. lay out the company's vision for the future,&#8221; Ives said.
&#8220;We remain confident in the Tesla story which has proven successful many times over the years, and we look forward to this long-awaited event as the next evolution of transportation unfolds.&#8221;
TSLA Price Action: Tesla shares are up approximately 22% over the past month. The stock closed Tuesday up 0.45% at $261.63, according to<a href="http://pro.benzinga.com"> Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41086839/tesla-cybertruck-starts-receiving-highly-anticipated-fsd-software">Tesla Cybertruck Starts Receiving Highly Anticipated FSD Software</a></li>
</ul>
Photo: Courtesy of Tesla.

Analyst Color

News

Events

Tech

TSLA

Tesla Analyst Sets The Stage For 'Game Changing' Robotaxi Event, Anticipates 'Seminal And Historical Day For Musk And Tesla'

Baxter International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAX#NYSE">BAX</a>). has shut down its largest manufacturing facility following significant damage caused by Hurricane Helene. The hurricane, which hit the Southeast of the U.S. with deadly force, triggered power outages and flooding across the region.
Baxter's North Cove plant, located in Marion, North Carolina, is the nation's biggest producer of intravenous and peritoneal dialysis solutions. The company has stated that this disruption will likely have a negative effect on its financial performance.
On Monday, Baxter's shares initially fell as much as 4.1%, but later settled at a 2.3% decline, trading at $38.01 by midday in New York. Baxter&#8217;s stock ended up closing right below $38 a share Monday. Read Also: <a href="https://www.benzinga.com/news/24/09/41082452/hurricane-helene-exposes-vulnerability-of-floridas-home-insurance-market">Hurricane Helene Exposes Vulnerability Of Florida&#8217;s Home Insurance Market</a> Patrick Wood, an equity analyst at Morgan Stanley, covered the hurricane-related disruption in a note Monday, outlining the potential financial harm caused by the storm. Wood pointed to a 2017 hurricane, which impacted Baxter&#8217;s capacity in Puerto Rico, as a precedent for Hurricane Helene. &#8220;To sense check, if we assumed a $140mn impact in BAX's Q4 (given Q3 is essentially over), that implies about 4 days worth of shutdown for the entire US Chronic Therapies and Infusion Therapies businesses,&#8221; Wood wrote in the note. &#8220;Though in reality more given this is unlikely the only facility where PD and IV solutions are produced and BAX can presumably shift capacity around.&#8221;
Hurricane Helene, a Category 4 storm, struck Florida on Thursday with winds reaching 140 miles per hour and moved northward. The storm caused severe flooding, including a levee breach that sent water into Baxter&#8217;s facility. The flooding damaged stock and raw materials, according to a company spokesperson.
It remains unclear if the plant closure will affect medical procedures in the U.S., though Wells Fargo analysts noted that other companies, such as ICU Medical, Fresenius Kabi and B Braun SE, may be able to compensate for Baxter's supply loss.
Baxter is working closely with local officials to bring the North Cove plant back online. Fortunately, none of the facility's 2,500 employees were injured. However, the company is still verifying the safety of its workforce as communication in the area has been hampered by outages in cellular service. Keep Reading: • <a href="https://www.benzinga.com/24/09/41082266/hurricane-helene-devastates-southeastern-u-s-slamming-infrastructure-and-leaving-millions-powerless">Hurricane Helene Devastates Southeastern U.S., Slamming Infrastructure And Leaving Millions Powerless</a>

Photo: Unsplash

Health Care

Trading Ideas

General

Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina

NXRT

NexPoint Residential Trust Says Its Properties Did Not Sustain Any Material Damages Due To Hurricane Helene

First Security Bancorp and its wholly owned subsidiary, First Security Trust and Savings Bank, will combine with Byline Bancorp, Inc. in a cash and stock transaction valued at approximately&nbsp;$41.0 million&nbsp;based upon Byline&#39;s closing stock price as of September 27, 2024.
Under the terms of the definitive merger agreement, at the closing of the transaction, Byline will issue 2.1794 shares of its common stock for each outstanding share of First Security Bancorp common stock, or approximately 1.5 million shares to First Security Bancorp common stockholders, subject to adjustment per the terms of the agreement.
Based upon the closing price of Byline&#39;s common stock of&nbsp;$26.16&nbsp;on September 27, 2024, this represents a transaction value of approximately&nbsp;$38.4 million&nbsp;or&nbsp;$57.01&nbsp;per First Security Bancorp common share.&nbsp;
Outstanding First Security Bancorp preferred shares will be redeemed in cash at closing with an estimated aggregate value of approximately&nbsp;$2.6 million&nbsp;in accordance with the terms of the certificate of designation.

Byline Bancorp, First Security Bancorp Enter Definitive Merger Agreement; First Security To Combine With Byline Bancorp In Cash And Stock Transaction Valued At $41M

Apparel company Nike Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) will report first-quarter financial results Tuesday on the heels of recently naming a new CEO. Shares could be volatile after<a href="https://www.benzinga.com/earnings"> the earnings report.</a>
Earnings Estimates: Analysts expect the company to report first-quarter revenue of $11.64 billion, down from $12.94 billion in last year's first quarter, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent093024&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company has missed revenue estimates from analysts in three of the last four quarters but beaten estimates in seven of the last 10 quarters overall.
Analysts expect the company to report first-quarter earnings per share of 52 cents, down from 94 cents in last year's first quarter. The company has beaten analyst estimates for earnings per share in four straight quarters and nine of the last 10 quarters overall.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40964381/nike-ceo-announcement-icing-on-the-cake-for-bulls-8-analysts-react-to-elliot-hills-">Nike CEO Announcement &#8216;Icing On The Cake&#8217; For Bulls: 8 Analysts React To Elliot Hill&#8217;s Ascension</a>
What Analysts Are Saying: With the announcement that Elliot Hill is <a href="https://www.benzinga.com/news/24/09/40948580/nike-stock-jumps-9-after-the-bell-ceo-set-to-retire">returning to the company</a> and will be the new CEO, analysts have been raising their price targets.
Jefferies analyst Randal Konik maintained a Hold rating and raised the price target for Nike from $80 to $85 ahead of the earnings report.
"We believe investor expectations for F1Q are fairly low, as foot/web traffic data has remained soft and competitors continue to gain share," Konik said.
The analyst said there's "not much to get excited about yet" for Nike, but the incoming CEO will change things.
Hill's impact may not be felt until fiscal 2026, the analyst cautioned.
"Therefore, NKE shares are in ‘no man's land' and likely remain range-bound for a number of quarters."
Hill re-joining Nike is a positive development, the analyst added, with the change potentially improving culture and the company's wholesale channel.
"However, we are wary of ongoing challenges he will face."
One of the biggest catalysts for Nike is coming with an analyst day in November. The analyst said the analyst day, the company's first in seven years, could be pushed out with the change.
In the earnings report, Nike is likely to talk about the new Air Max and could also highlight upcoming products, the analyst added.
"While Nike is beginning a new multi-year product innovation cycle in 2H24, we foresee headwinds as the company works to control its current product assortment and wholesale partnerships."
Stifel analyst Jim Duffy recently maintained a Hold rating with a $79 price target.
The analyst said bringing back a long-time Nike insider should be viewed as a positive.
&#8220;Recent underperformance is a direct result of losing focus on what has made Nike great for so many years,&#8221; Duffy said. &#8220;Under Mr. Hill&#8217;s leadership, we hope to see a revitalization of the Nike culture and a renaissance in innovation and design.&#8221;
The analyst warns that changing CEOs can reset financial forecasts, trigger periods of product revitalization and potentially lead to additional management changes.
Key Items to Watch: While all the talk about Nike will be on the incoming CEO, the company likely won't share much new information about this leadership change before the move happens in mid-October.
Instead, investors will likely focus on the top- and bottom-line numbers with recent quarters showing strength in earnings per share and weakness in revenue versus Street estimates.
One of the biggest focuses from investors and analysts outside of the new CEO will likely be on the regional results. The fourth-quarter results showed strength in China and weakness in North America.
NKE Price Action: Nike stock was down 1.16% to $88.40 at market close on Monday versus a 52-week trading range of $70.75 to $123.39. Nike stock is down 17% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40957353/nikes-new-ceo-elliott-hill-to-focus-on-repairing-retailer-relations">Nike&#8217;s New CEO Elliott Hill To Focus On Repairing Retailer Relations</a></li>
</ul>
Photo: Shutterstock

Price Target

Previews

Reiteration

Sports

Analyst Ratings

Nike Q1 Earnings Preview: China, North America In Focus, Analyst Says 'Not Much To Get Excited About Yet' With CEO Change

The shares are expected to begin trading on the Nasdaq Capital Market under the ticker symbol &quot;HTLM&quot; on October 1, 2024. The Offering is expected to close on October 2, 2024, subject to customary closing conditions.

IPOs

HTLM

HomesToLife Prices IPO Of An Aggregate Of 1.25M Ordinary Shares At $4.00 Per Share

Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares traded nearly 9% higher Monday as the stock continues to move on volatility <a href="https://www.benzinga.com/government/24/09/41093811/whats-going-on-with-trump-media-technology-stock-on-monday">ahead of the Presidential election.</a>
The Details: Trump Media &amp; Technology shares have gained more than 30% over the past five days as the lockup period expiration date passed. 
Trump Media co-founders Andrew Litinsky and Wes Moss's United Atlantic Ventures sold over seven million shares of Trump Media last week. However, Trump maintained his plans not to sell his stake in the Truth Social parent and did not sell any shares. 
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41071876/mojo-is-back-at-tesla-says-tech-analyst-dan-ives-ahead-of-q3-deliveries">Tesla &#8216;Mojo Is Back,&#8217; Tech Analyst Dan Ives Says Ahead Of Q3 Deliveries</a>
What Else: Trump Media &amp; Technology announced after Monday's closing bell that its custom-built content delivery network (CDN) is <a href="https://www.benzinga.com/pressreleases/24/09/g41104106/trump-media-expands-tv-streaming-delivery-network-to-multi-site-operation">now operating</a> from multiple geographic sites across the country.
&#8220;We&#8217;re pleased to report our CDN is operating excellently and is quickly enhancing,&#8221; said TMTG CEO Devin Nunes. &#8220;With additional data centers expected to open soon, our TV streaming capabilities and content are expanding rapidly, consistent with Truth Social&#8217;s goal to become the unassailable fortress of free speech on the Internet.&#8221;
The content delivery network is currently accessible through the Truth Social platform and scheduled to be released soon as a stand-alone app. TMTG said it aims to create a robust TV streaming platform offering news, Christian content and family-friendly programming. 
DJT Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Trump Media &amp; Technology Group shares are up 1.68% at $16.32 after-hours after climbing 8.95% in Monday's regular trading session.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41070564/amazon-prime-day-data-insights-before-october-event-apple-purchases-up-22-celsius-tops-grocery-categ">Amazon Prime Day Data Insights Before October Event: Apple Purchases Up 22%, Celsius Tops Grocery Category</a></li>
</ul>
Photo: Pete Linforth from Pixabay

After-Hours Center

Movers

What Happened With Trump Media & Technology Stock Today?

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) has outperformed the market over the past 5 years by 6.82% on an annualized basis producing an average annual return of 21.1%. Currently, Fluor has a market capitalization of $8.17 billion. 
Buying $1000 In FLR: If an investor had bought $1000 of FLR stock 5 years ago, it would be worth $2,644.68 today based on a price of $47.71 for FLR at the time of writing.
<h3>Fluor's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727731818_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Fluor 5 Years Ago Would Be Worth This Much Today

Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) has outperformed the market over the past 20 years by 2.4% on an annualized basis producing an average annual return of 10.85%. Currently, Global Payments has a market capitalization of $25.70 billion. 
Buying $100 In GPN: If an investor had bought $100 of GPN stock 20 years ago, it would be worth $777.09 today based on a price of $101.00 for GPN at the time of writing.
<h3>Global Payments's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727731813_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Global Payments 20 Years Ago Would Be Worth This Much Today

Billionaire Mark Cuban recently <a href="https://www.benzinga.com/24/09/41075742/mark-cuban-as-treasury-secretary-no-head-of-the-sec-is-the-job-hed-take-because-gary-gensler-has-bee">expressed interest in leading</a> the Securities and Exchange Commission (SEC), criticizing the agency&#8217;s handling of cryptocurrency regulations under current Chair Gary Gensler.
As a well-known NBA team owner and <a href="https://www.benzinga.com/markets/cryptocurrency/21/03/20070630/dogecoin-gets-mark-cuban-boost-but-its-no-match-to-this-nft-cryptos-spiciness">advocate for digital assets</a> like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), Cuban has frequently used his platform, along with Tesla CEO Elon Musk, to influence the meme coin's price through public support.
Here's a look at how investing in Dogecoin based on a Cuban event would have turned out.
What Happened: On March 4, 2021, <a href="http://www.benzinga.com/markets/cryptocurrency/21/03/20021204/mark-cubans-dallas-mavericks-now-accept-meme-crypto-dogecoin">Cuban announced that</a> the National Basketball Association's Dallas Mavericks would accept Dogecoin as payment for tickets and merchandise.
"The Dallas Mavericks are a long-time enthusiast of cryptocurrency, opening up new opportunities for the team to sell tickets and merchandise to its global MFFL fan base," said BitPay CEO Stephen Pair at the time. BitPay worked with the Mavericks to make the move happen.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024" target="_blank" rel="noreferrer noopener">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
One of the biggest explanations Cuban gave as to why the Mavericks made the decision to accept Dogecoin was "Because we can!" "The Mavericks have decided to accept Dogecoin as payment for Mavs tickets and merchandise for on very important, earth shattering reason, because we can!" Cuban said at the time.
Cuban said sometimes you have to do fun things that could generate a lot of PR for your company or team.
The Mavericks saw $122,000 r<a href="http://'Supply And Demand Is Undefeated': Mark Cuban Celebrates Dallas Mavericks' Dogecoin Merch Sales">ecognized in Dogecoin sales </a>over its first month and set several 24-hour records with strong demand for using the meme coin towards merchandise.
Cuban <a href="http://www.benzinga.com/markets/cryptocurrency/21/08/22504769/mark-cuban-reveals-how-much-dogecoin-he-owns">revealed later in 2021</a> that he personally owned $494 in Dogecoin, and the Mavericks own whatever they have collected from the merchandise and ticket sales.
"If I had to choose between buying a lottery ticket and #Dogecoin… I would buy #Dogecoin," Cuban tweeted in February 2021.
Supporting Dogecoin even further, the Mavericks<a href="https://www.benzinga.com/markets/cryptocurrency/21/08/22709857/dallas-mavericks-offering-25-gift-cards-for-customers-buying-merch-with-dogecoin-during-do"> offered a promotion </a>to support the meme crypto in August 2021. All customers who used Dogecoin to make purchases online totaling $150 or more received a free $25 e-gift card. The event was part of a Dogemania event.
The early support for Dogecoin and the promotion by the Mavericks wasn't lost on Dogecoin co-founder Billy Markus.
"If you wanna support one of the first big name vendors to evangelize DOGE for purchases, as @mcuban says, it's ready for you," Markus tweeted at the time.
Investing With Cuban, the Mavericks: Sometimes big events in the cryptocurrency or Dogecoin world can be catalysts that drive the price higher.
Dogecoin hit a high of $.05109 on the day of the Maverick's March announcement. A $1,000 investment in Dogecoin at the time could have purchased 19,573.30 Dogecoin.
Based on a <a href="http://www.benzinga.com/money/todays-dogecoin-price/">price </a>of $0.1185 for Dogecoin at the time of writing, the same $1,000 investment would be worth $2,319.44 today. This marks a +131.9% over the last three and a half years. 
Dogecoin <a href="https://www.benzinga.com/markets/cryptocurrency/21/12/24814327/2021-was-the-year-of-dogecoin-a-month-by-month-retrospective-with-top-stories">hit an all-time high</a> of $0.7375 in May 2021, a couple of months after the Mavericks began supporting the cryptocurrency. At its peak, the $1,000 investment based on the March announcement was worth $14,435.31.
Dogecoin has traded between $0.05747 and $0.2266 over the last 52 weeks. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41096120/if-you-invested-1-000-in-bitcoin-when-donald-trump-said-he-wasnt-a-fan-heres-how-much-youd">If You Invested $1,000 In Bitcoin When Donald Trump Said He Wasn&#8217;t A Fan, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
Photo: Courtesy of&nbsp;<a href="https://www.flickr.com/photos/gageskidmore/" target="_blank" rel="noreferrer noopener">Gage Skidmore</a>&nbsp;on flickr

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Topics

$DOGE

If You Invested $1,000 In Dogecoin When Mark Cuban And The Dallas Mavericks Welcomed The Meme Crypto, Here's How Much You'd Have Now

Offerings

Terex Prices Private Offering Of $750M Of 6.250% Senior Notes Due 2032 At Par

The Company anticipates that these cost reductions will result in overhead savings of&nbsp;$54 million&nbsp;on an annualized run-rate basis and will lower the Company&#39;s revenue break-even point from less than&nbsp;$430 million&nbsp;of annual revenue to less than&nbsp;$225 million&nbsp;of annual revenue.
The company continues to expect revenue in the range of&nbsp;$97 million&nbsp;to&nbsp;$107 million

Guidance

The Beachbody Company, Inc. Class A Common Stock

BODI

Beachbody's MLM Network To Begin Winding Down; Reaffirms Its Financial Guidance For Q3, With Revenue At $97M - $107M, Est $103.586M

BODi will transition from its current Multi-Level Marketing (MLM) Network channel to a single-level Affiliate Program, which will launch November 1, 2024.
Current participants in the Team BODi Partner Network in the United States and Canada will transition to the new Affiliate Program that is focused on being more productive and rewarding for a larger group of sellers.
&nbsp;

Beachbody Expects To Significantly Improve Revenue Break-Even Point, Decreasing From Less Than $430M In Annual Revenue To Less Than $225M

Reduces Its Workforce By Approximately 33 Percent

Beachbody Reduces Its Workforce By Approximately 33%; Reduces Costs, Broadens Distribution Channels

At the Tokyo Game Show (TGS) over the weekend, Hideo Kojima captivated fans during a 90-minute stage event, unveiling new details about Sony Group Corp.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) <a href="https://www.benzinga.com/general/gaming">Death Stranding 2: On The Beach. </a>
With the game set for release in 2025, Kojima's presentation focused on character reveals, voice casting and innovative gameplay features that promise to enhance the player experience.
See Also: <a href="https://drupal-cloudfront.benzinga.com/general/gaming/24/02/36896613/sonys-playstation-2024-state-of-play-updates-on-death-stranding-2-sonic-x-shadow-generations-silen">Sony&#8217;s PlayStation 2024 State Of Play: Updates On Death Stranding 2, Sonic x Shadow Generations, Silent Hill Among Other Exciting Reveals</a>
<h1 class="wp-block-heading">A Triumphant Return to TGS</h1>
This year marked Kojima&#8217;s return to TGS after a five-year hiatus since 2019, when he last appeared to promote the original Death Stranding. 
<a href="https://www.ign.com/articles/hideo-kojima-death-stranding-2-tgs">According </a>to IGN, The event welcomed an enthusiastic audience, eager to hear from the renowned game designer. Joining Kojima on stage were singer-songwriter Daichi Miura and voice actors Kenjiro Tsuda, Nana Mizuki, Tomokazu Sugita and Shion Wakayama, alongside Danish film director Nicolas Winding Refn.
During the presentation, Kojima highlighted the Japanese voice cast for the sequel. Tsuda and Mizuki will reprise their roles as Sam and Fragile, respectively. Sugita, known for his dynamic voice work, will lend his talents to Dollman, a small yet significant character seen in early footage interacting with Sam.
The appearance of Wakayama, who recently won the Best New Actor award at the 2023 Seiyu Awards, introduced Tomorrow, a character inspired by actress Elle Fanning. 
A preview showed Tomorrow engaging in a conversation with Rainy, played by Shioli Kutsuna, who also expressed her admiration for Kojima through a pre-recorded video message. &#8220;I had never experienced a shoot like this before,&#8221; Kutsuna stated.
<h1 class="wp-block-heading">Innovative Photo Mode And Merchandise</h1>
Kojima showcased the game&#8217;s new photo mode, allowing players to interact with characters like Fragile, Tomorrow and Sunny in a more engaging manner.
Kojima exlplained: &#8220;You can create Polaroid-like images of these moments.&#8221; The demo featured Dollman dancing alongside Sam, as players enjoyed the ability to manipulate camera angles in real time.
In addition to gameplay features, Kojima revealed plans for exclusive merchandise, designed in collaboration with renowned designer Errolson Hugh and artist Yoji Shinkawa. 
The new Death Stranding jackets, retailing at approximately $1,749 (248,600 yen), will cater to both fans and characters in the game. A pop-up shop is also set to open at PARCO Shibuya in Tokyo on Nov. 8, celebrating the fifth anniversary of the original game&#8217;s launch.
<h1 class="wp-block-heading">Anticipation For Release</h1>
Despite the excitement surrounding the game&#8217;s features, Kojima kept fans in the dark regarding the release date, 
While he confirmed that principal photography was completed in May, he noted that the game&#8217;s development is only &#8220;30 to 40% complete,&#8221; <a href="https://ign.com/articles/hideo-kojima-death-stranding-2-tgs">as per</a> IGN.
Kojima hinted the release date is set internally but declined to disclose it, citing &#8220;unforeseen circumstances&#8221; that prevent him from sharing specific details at this time.
&#8220;I haven&#8217;t said the release date today, but the release date has already been decided, and I&#8217;m currently working on it in preparation for that,&#8221; Kojima stated. He promised fans that more information would be revealed &#8220;at some point next year.&#8221;
Read Next:
<ul>
<li><a href="https://benzinga.com/general/gaming/24/02/36900700/kojima-productions-announces-physint-a-cutting-edge-action-espionage-game-a-strategic-move-for-pla">Kojima Productions Announces &#8216;Physint&#8217;: A Cutting-Edge Action Espionage Game, A Strategic Move For PlayStation 6?</a></li>
</ul>
Photo: Shutterstock.

Gaming

Sony Group Corporation American Depositary Shares

SONY

What We Learned About Death Stranding 2 At Tokyo Game Show 2024

Duke Energy Says Restored 1.35M Customer Outages In The Carolinas Following Helene

This transaction is expected to close on November 30, 2024, and will return IAMGOLD to its full&nbsp;70%&nbsp;interest in C&ocirc;t&eacute; Gold.

IAMGOLD Submits Formal Notice To Sumitomo Metal Mining For Repurchase Of 9.7% Cote Gold Mine Interest

9 analysts have expressed a variety of opinions on Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Coterra Energy and provided 12-month price targets. The average target is $30.33, accompanied by a high estimate of $34.00 and a low estimate of $26.00. A 7.78% drop is evident in the current average compared to the previous average price target of $32.89. 
<img src="https://www.benzinga.com/files/images/story/2024/1727730093_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The perception of Coterra Energy by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$31.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$31.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$27.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$26.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$30.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Leo Mariani</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$29.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$34.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$34.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Coterra Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Coterra Energy compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Coterra Energy's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Coterra Energy's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CTRA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coterra Energy analyst ratings.</a>
<h2>Get to Know Coterra Energy Better</h2>
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and NGLs. The company's operations are primarily concentrated in three core operating areas; the Permian Basin in west Texas and southeast New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin in the Mid-Continent region in Oklahoma.
<h3>Unraveling the Financial Story of Coterra Energy</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Coterra Energy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.26% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Coterra Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 17.23%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Coterra Energy's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.68%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Coterra Energy's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.05%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Coterra Energy's debt-to-equity ratio is below the industry average at 0.23, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTRA

Demystifying Coterra Energy: Insights From 9 Analyst Reviews

During the last three months, 11 analysts shared their evaluations of Citizens Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $44.36, a high estimate of $50.00, and a low estimate of $37.00. Marking an increase of 10.4%, the current average surpasses the previous average price target of $40.18. 
<img src="https://www.benzinga.com/files/images/story/2024/1727730086_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Citizens Financial Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$46.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$50.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Scott Siefers</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Terry McEvoy</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$42.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Erika Najarian</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$46.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Ryan Merkel</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$49.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Gerard Cassidy</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$43.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$46.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$41.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$40.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Ken Usdin</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Citizens Financial Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Citizens Financial Group compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Citizens Financial Group's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Citizens Financial Group's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CFG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Citizens Financial Group analyst ratings.</a>
<h2>Get to Know Citizens Financial Group Better</h2>
Citizens Financial Group is a bank holding company headquartered in Providence, Rhode Island. Its two primary business segments are consumer banking and commercial banking. Citizens offers a mix of retail and commercial products including capital markets and wealth options. The bank has over 1,100 branches in 14 states, although it is concentrated in the Northeast. It has over $220 billion of total assets. It generates maximum revenue from Consumer Banking Segment.
<h3>Citizens Financial Group: Delving into Financials</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Citizens Financial Group's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -6.45%. This indicates a decrease in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Citizens Financial Group's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 18.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.64%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Citizens Financial Group's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.16%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Citizens Financial Group's debt-to-equity ratio stands notably higher than the industry average, reaching 0.6. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Unveiling 11 Analyst Insights On Citizens Financial Group

During the last three months, 11 analysts shared their evaluations of Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $22.48, a high estimate of $26.00, and a low estimate of $20.00. This current average represents a 8.13% decrease from the previous average price target of $24.47. 
<img src="https://www.benzinga.com/files/images/story/2024/1727730076_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Franklin Resources. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alexander Blostein</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$21.25</td>
<td>$23.75</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>-</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Announces</td>
<td>Underweight</td>
<td>$20.00</td>
<td>-</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Maintains</td>
<td>Underperform</td>
<td>$23.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Brian Bedell</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$23.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$24.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$23.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Etienne Ricard</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$26.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$24.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$23.00</td>
<td>$25.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Franklin Resources. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Franklin Resources compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Franklin Resources's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BEN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Franklin Resources analyst ratings.</a>
<h2>All You Need to Know About Franklin Resources</h2>
Franklin Resources provides investment services for individual and institutional investors. At the end of August 2024, Franklin had $1.681 trillion in managed assets, composed primarily of equity (36%), fixed-income (34%), multi-asset/balanced (10%) funds, alternatives (15%) and money market funds (5%). Distribution tends to be weighted equally between retail investors (52% of AUM) and institutional accounts (46%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 30% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.
<h3>Franklin Resources's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Franklin Resources's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 7.82%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Franklin Resources's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 7.84%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Franklin Resources's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.29%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Franklin Resources's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.5%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Franklin Resources's debt-to-equity ratio is below the industry average at 1.06, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 11 Analyst Projections For Franklin Resources

NINE, HUSA and TAOP are among premarket gainers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Zhongchao&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>) stock is rocketing higher on Friday alongside heavy trading of the Chinese healthcare information and training company&rsquo;s shares.



That has more than 11.9 million shares of ZCMD stock changing hands as of this writing. This is well above its daily average trading volume of about 390,000 shares. Investors will also note that the float for Zhongchao&nbsp;is <a href="https://finance.yahoo.com/quote/ZCMD/key-statistics">only about 1.3 million units</a>.



The increase in activity for ZCMD stock today comes without any news from the company. That includes a lack of press releases or filings with the Securities and Exchange Commission (SEC). There&rsquo;s also no new analyst news that would send shares higher today.



It&rsquo;s also worth keeping in mind that ZCMD is a penny stock. That comes from its prior closing price of $1.45 per share and its market capitalization of $3.581 million.



<h2>What That Means for ZCMD Stock</h2>



Being a penny stock opens ZCMD shares up to certain vulnerabilities. Among them is volatility and manipulation from certain types of traders. Its low float also plays into that compared to the heavy trading today.



All of this is to say that ZCMD stock may be undergoing a short squeeze right now. While that has the stock up at the moment, it also means the shares could come crashing back down soon. This makes it a risky investment for traders today.



ZCMD stock is up 102.8% as of Friday morning. However, the shares closed out Thursday down 54.6% year-to-date.



Investors will find more of the most recent stock market stories below!



We have all of the hottest stock market news ready to go on Friday! Among that is what has shares of Redwoods Acquisition&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock up, the biggest pre-market stock movers this morning and more. All of that news is available at the following links!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">Why Is Redwoods Acquisition (RWOD) Stock Up 72% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-april-19th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Friday</a></li>



<li><a href="https://investorplace.com/2024/04/li-stock-alert-li-auto-launches-new-li-l6-suv/">LI Stock Alert: Li Auto Launches New Li L6 SUV</a></li>
</ul>On <a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a> and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-zhongchao-zcmd-stock-up-103-today/">Why Is Zhongchao (ZCMD) Stock Up 103% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Zhongchao (ZCMD) Stock Up 103% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Tritium DCFC&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock is falling hard on Friday after the company <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318241881&amp;type=PDF&amp;symbol=DCFC&amp;cdn=21bc4c0fb2af1dc1e7b76f221263a80e&amp;companyName=Tritium+DCFC+Limited&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-18">warned investors of insolvency</a> in a filing with the Securities and Exchange Commission (SEC).



This filing from Tritium DCFC notes that it and three of its Australian subsidiaries are insolvent or likely to become insolvent. It also mentions that an administrator should be appointed under the Australian Corporations Act 2001.



Tritium DCFC has appointed t Peter James Gothard, James Douglas Dampney and William Martin Colwell of KPMG as joint and several administrators. With this comes the suspension of the powers of the company&rsquo;s Board of Directors.



Finally, the company notes that this voids the transfer of shares during this period. The only exceptions are those made by the administrators or through a court.



<h2>DCFC Stock Troubles</h2>



Today&rsquo;s news builds on problems that Tritium DCFC was already facing. That includes <a href="https://www.nasdaq.com/press-release/tritium-receives-nasdaq-staff-determination-letter-2024-04-11">a delisting warning</a> that was sent to it earlier this month. The problem is it not meeting the minimum of 1,100,000 publicly held shares to remain on the exchange.



Tritium DCFC was planning to meet with the Nasdaq Hearings Panel to discuss regaining compliance with this standard. It&rsquo;s unclear how the insolvency filing affects this.



DCFC stock is down 63.1% as of Friday morning and was down 91.5% year-to-date when markets closed yesterday.



Investors looking for more of the most recent stock market stories are in the right place!



InvestorPlace is home to all of the hottest stock market news for Friday! A few examples include what&rsquo;s happening with shares of Zhongchao&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>)&nbsp;and Redwoods Acquisition&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock as well as the biggest pre-market stock movers this morning.



<h2>More Friday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-zhongchao-zcmd-stock-up-103-today/">Why Is Zhongchao (ZCMD) Stock Up 103% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">Why Is Redwoods Acquisition (RWOD) Stock Up 72% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-april-19th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Friday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-tritium-dcfc-dcfc-stock-down-63-today/">Why Is Tritium DCFC (DCFC) Stock Down 63% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Tritium DCFC (DCFC) Stock Down 63% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
BioNexus Gene Lab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) stock is falling on Friday but investors will note that this comes after its shares underwent a rally late on Thursday.



BioNexus Gene Lab shares closed out Thursday up 28.8% with about 3.1 million units traded. That was more than its daily average trading volume of about 1.6 million shares.



The catalyst for this rally was BioNexus Gene Lab announcing its agreement to <a href="https://www.nasdaq.com/press-release/bionexus-gene-lab-corp.-agrees-to-invest-rm-1.2-million-in-ascension-innovation-aisb">invest $250,000 in Ascension Innovation</a>. This is a privately held Malaysian company focused on advancing digital health information with artificial intelligence (<a href="https://investorplace.com/stock-quotes/ai-stock-quote/">AI</a>).



Sam Tan, CEO, BioNexus Gene Lab, said this about the news.




&ldquo;Our investment in AISB reflects our belief in their transformative healthcare solutions. Together, we aim to revolutionize patient care through predictive and generative AI.&rdquo;




AI has been a hot topic lately with news of it often raising a company&rsquo;s shares. Yesterday&rsquo;s gains were likely the result of traders flocking to BGLC stock due to the AI connection with this investment.



<h2>BGLC Stock Movement on Friday</h2>



Unfortunately, it doesn&rsquo;t look like BGLC is able to maintain the positive movement it saw yesterday. This has the stock down 26.8% during pre-market hours on Friday. However, this doesn&rsquo;t come with heavy trading as only around 66,000 units have changed hands this morning.



Investors will see even more of the latest stock market stories below!



We have all of the hottest market news traders need to know about on Friday! That includes everything happening with shares of Tritium DCFC&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock, Zhongchao&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>) stock and Redwoods Acquisition&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock today. You can catch up on all of these matters at the following links!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-tritium-dcfc-dcfc-stock-down-63-today/">Why Is Tritium DCFC (DCFC) Stock Down 63% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-zhongchao-zcmd-stock-up-103-today/">Why Is Zhongchao (ZCMD) Stock Up 103% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">Why Is Redwoods Acquisition (RWOD) Stock Up 72% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-bionexus-gene-lab-bglc-stock-down-27-today/">Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?

Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers

INDO, IPDN and GSUN among mid-day movers

SBFM, BPTH and INDO among pre-market losers

ING, PALI and FNCH among pre-market losers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!



Earnings reports, an acquisition deal and more are behind today&rsquo;s biggest stock market movements.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Zhongchao (NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>) stock is rocketing 78% higher alongside heavy pre-market trading.</li>



<li>G1 Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/gthx-stock-quote/">GTHX</a>) shares are soaring more than 65% on <a href="https://finance.yahoo.com/news/pharmacosmos-group-acquire-g1-therapeutics-102900391.html">an acquisition deal</a>.</li>



<li>Richtech Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rr-stock-quote/">RR</a>) stock is surging over 48% with strong early morning trading.</li>



<li>AlphaVest Acquisition Corp &ndash; Right (NASDAQ:<a href="https://investorplace.com/stock-quotes/atmvr-stock-quote/">ATMVR</a>) shares are gaining more than 46% this morning.</li>



<li>Inogen (NASDAQ:<a href="https://investorplace.com/stock-quotes/ingn-stock-quote/">INGN</a>) stock is increasing over 31% with its <a href="https://www.nasdaq.com/press-release/inogen-announces-second-quarter-2024-financial-results-2024-08-06">Q2 earnings report</a>.</li>



<li>Upstart (NASDAQ:<a href="https://investorplace.com/stock-quotes/upst-stock-quote/">UPST</a>) shares are rising more than 25% after <a href="https://finance.yahoo.com/news/upstart-holdings-inc-upst-reports-221010260.html">reporting a Q2 revenue beat</a>.</li>



<li>Lumen Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/lumn-stock-quote/">LUMN</a>) stock is heading over 24% higher <a href="https://www.fool.com/earnings/call-transcripts/2024/08/06/lumen-technologies-lumn-q2-2024-earnings-call-tran/">with its latest earnings</a>.</li>



<li>Veracyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/vcyt-stock-quote/">VCYT</a>) shares are climbing close to 22% after <a href="https://www.nasdaq.com/press-release/veracyte-announces-second-quarter-2024-financial-results-2024-08-06">announcing its Q2 results</a>.</li>



<li>Direxion Shares ETF Trust Direxion Daily Electric and Autonomous Vehicles Bull 2X Shares (NYSEARCA:<a href="https://investorplace.com/stock-quotes/evav-stock-quote/">EVAV</a>) are jumping more than 19% this morning.</li>



<li>Shopify (NYSE:<a href="https://investorplace.com/stock-quotes/shop-stock-quote/">SHOP</a>) stock is up 18% on <a href="https://za.investing.com/news/stock-market-news/shopify-stock-soars-on-solid-q2-report-issues-q3-guidance-432SI-3275444">solid Q2 earnings results</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Scorpius (NYSEMKT:<a href="https://investorplace.com/stock-quotes/scpx-stock-quote/">SCPX</a>) shares are crashing over 79% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318500722&amp;type=PDF&amp;symbol=SCPX&amp;cdn=70e2821112bdd2f31adb78fe13cd4e38&amp;companyName=Scorpius+Holdings+Inc.&amp;formType=FWP&amp;formDescription=Filing+under+Securities+Act+Rules+163%2F433+of+free+writing+prospectuses&amp;dateFiled=2024-08-07">proposed public offering</a>.</li>



<li>Talis Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlis-stock-quote/">TLIS</a>) stock is plummeting more than 47% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318499549&amp;type=PDF&amp;symbol=TLIS&amp;cdn=2a3bd0b3e041ab6a71139ad061fc0a12&amp;companyName=Talis+Biomedical+Corporation&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-08-06">on restructuring updates</a>.</li>



<li>DZS (NASDAQ:<a href="https://investorplace.com/stock-quotes/dzsi-stock-quote/">DZSI</a>) shares are diving over 45% as it <a href="https://www.nasdaq.com/press-release/dzs-receives-expected-delisting-notice-nasdaq-2024-08-06">prepares for a delisting notice</a>.</li>



<li>Stem (NYSE:<a href="https://investorplace.com/stock-quotes/stem-stock-quote/">STEM</a>) stock is tumbling 38% <a href="https://finance.yahoo.com/news/stem-inc-stem-reports-q2-221513320.html">on Q2 misses</a>.</li>



<li>Nevro (NYSE:<a href="https://investorplace.com/stock-quotes/nvro-stock-quote/">NVRO</a>) shares are taking a more than 37% beating after <a href="https://www.marketwatch.com/story/nevro-shares-fall-21-cuts-2024-revenue-outlook-75cf8aa9?mod=newsviewer_click">cutting its revenue outlook</a>.</li>



<li>Emergent BioSolutions (NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) stock is sliding over 35% <a href="https://www.stocktitan.net/news/EBS/emergent-bio-solutions-reports-second-quarter-2024-financial-h8fhmjurwquo.html">alongside its Q2 results</a>.</li>



<li>VBI Vaccines (NASDAQ:<a href="https://investorplace.com/stock-quotes/vbiv-stock-quote/">VBIV</a>) shares are dropping more than 34% <a href="https://investorplace.com/2024/08/why-is-vbi-vaccines-vbiv-stock-up-62-today/">after a rally yesterday</a>.</li>



<li>Expion360 (NASDAQ:<a href="https://investorplace.com/stock-quotes/xpon-stock-quote/">XPON</a>) stock is decreasing over 28% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318500633&amp;type=PDF&amp;symbol=XPON&amp;cdn=cc4a67ceca06cec716b8eaa852fb2069&amp;companyName=Expion360+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-08-06">with a public offering</a>.</li>



<li>Evotec (NASDAQ:<a href="https://investorplace.com/stock-quotes/evo-stock-quote/">EVO</a>) shares are falling more than 22% <a href="https://www.investing.com/news/stock-market-news/evotec-shares-crash-36-on-profit-warning-3558654">on a profit warning</a>.</li>



<li>CryoPort (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyrx-stock-quote/">CYRX</a>) stock closes out our pre-market stock movers down over 20% after <a href="https://finance.yahoo.com/news/cryoport-inc-cyrx-reports-q2-230011376.html">missing Q2 estimates</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-aug-7th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Zhongchao&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>) stock is on the rise Wednesday alongside heavy pre-market trading of the healthcare information company&rsquo;s shares.



This has more than 12 million shares of ZCMD stock changing hands as of this writing. That&rsquo;s a massive leap over its daily average trading volume of about 58,000 shares. Investors will also note it has a low float <a href="https://finance.yahoo.com/quote/ZCMD/key-statistics/">at 1.29 million units</a>.



All of this movement comes without any clear news from Zhongchao. That includes a lack of press releases or filings with the Securities and Exchange Commission (SEC). There&rsquo;s also no analyst coverage that would cause the stock to rally today.



What is worth keeping in mind is ZCMD&rsquo;s status as a penny stock. This comes from its prior closing price of $1.09, low daily average trading volume and its market capitalization of only $2.748 million.



<h2>What That Means for ZCMD Stock</h2>



Being a penny stock opens Zhongchao&nbsp;shares up to certain vulnerabilities. Among these is volatility from heavy trading even with a lack of news.



It&rsquo;s possible this is tied to speculative traders buying the stock while its low. It could also be an attempt at a pump and dump by retail and day traders. One thing is for sure, traders will want to be careful about taking a stake in the company right now.



ZCMD stock is up 52% as of Wednesday morning.



There are more stock market stories investors need to know about below!



We have all of the hottest stock market news ready to go on Wednesday! That includes the biggest pre-market stock movers this morning and other news. All of that is available at the following links!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-aug-7th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Wednesday</a></li>



<li><a href="https://investorplace.com/2024/08/trade-of-the-day-cinemark-cnk-stock-may-ride-higher-on-a-short-squeeze/">Trade of the Day: Cinemark (CNK) Stock May Ride Higher on a Short Squeeze</a></li>



<li><a href="https://investorplace.com/2024/08/nvidia-news-new-street-research-upgrades-nvda-stock-amid-selloff/">Nvidia News: New Street Research Upgrades NVDA Stock Amid Selloff</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-zhongchao-zcmd-stock-up-52-today/">Why Is Zhongchao (ZCMD) Stock Up 52% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Zhongchao (ZCMD) Stock Up 52% Today?

AEON

AGBA

ALLR

ATMVR

BACK

BGLC

BIMI

BROG

CHRO

CYRX

CZOO

DCFC

DZSI

EDBL

EGOX

ENPH

EVAV

FNCH

GSUN

GTHX

HEPA

HUBC

INDO

INGN

INVO

IPDN

LUMN

MDIA

MNDR

NKGN

NURO

NVFY

NVRO

PAAS

PALI

PAPL

POAI

RWOD

SBFM

SCPX

SERV

SHOP

SILO

SMCI

STEM

SUGP

TLIS

TRSG

UPST

VBIV

VCYT

VZLA

XPON

YYAI

ZCMD

Contracts

Press Releases

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

Zhongchao Inc. Announces 1-for-10 Share Consolidation

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

Comments

ZHONGCHAO

Notizie

Ultime notizie per ZHONGCHAO (NASDAQ:ZCMD) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO